A panelist discusses how personalized ITP care requires open conversations about testing costs, insurance coverage, and treatment accessibility, with clinicians helping patients navigate financial ...

Immune thrombocytopenia (ITP) is a rare condition that causes a low platelet count. People with ITP can experience life threatening bleeding if the condition is not treated. Many people with ITP go ...

An expert discusses how rilzabrutinib uniquely improves quality-of-life metrics, including fatigue and women’s health domains, which previous immune thrombocytopenia (ITP) therapies failed to address ...

Thrombocytopenia-absent radius syndrome is a rare congenital condition. It causes a low platelet count and the absence of the radius bone in both forearms. Thrombocytopenia occurs when the number of ...

Immune thrombocytopenia (ITP) is an autoimmune disease in which IgG antiplatelet antibodies accelerate platelet clearance and reduce platelet production. The prevalence of ITP is approximately 1 to 3 ...

Children with newly diagnosed immune thrombocytopenia (ITP) treated with eltrombopag as a frontline therapy show significantly improved platelet responses and other outcomes compared with the standard ...

Please provide your email address to receive an email when new articles are posted on . Adding ianalumab to second-line eltrombopag prolonged time to treatment failure by more than 40%. Researchers ...

The European Medicines Agency (EMA) has recommended granting marketing authorization for rilzabrutinib (Wayrilz, Sanofi) to treat immune thrombocytopenia (ITP) in adults who are refractory to other ...

Have you ever felt like your body isn’t quite playing by the rules? Living with Immune Thrombocytopenia (ITP) can sometimes feel like an unpredictable journey, with fluctuating platelet levels and ...